Gloucester Pharmaceuticals, Inc. Gears Up for FDA Panel Vote on Lymphoma Drug

Bookmark and Share

Xconomy.com -- You can bet that the people who just put $29 million into Gloucester Pharmaceuticals a few days ago will be watching very closely today for signs they got their money’s worth.
MORE ON THIS TOPIC